Ascorbic acid supplementation in the treatment of pressure-sores

Lancet. 1974 Sep 7;2(7880):544-6. doi: 10.1016/s0140-6736(74)91874-1.

Abstract

In a prospective double-blind controlled trial the effect of large doses of ascorbic acid on the healing of pressure-sores has been assessed. 20 surgical patients were studied, the pressure areas being assessed by serial photography and ulcer tracings. The mean ascorbic-acid levels in treated and non-treated groups one month after the start of treatment were 65.6 and 25.8 mug per 10-8 white blood-cells. In the group treated with ascorbic acid there was a mean reduction in pressure-sore area of 84% after one month compared with 42.7% in the placebo group. These findings are statistically significant (P less than 0.005) and suggest that ascorbic acid may accelerate the healing of pressure-sores.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Aged
  • Arthritis, Rheumatoid / surgery
  • Ascorbic Acid / administration & dosage
  • Ascorbic Acid / blood
  • Ascorbic Acid / pharmacology
  • Ascorbic Acid / therapeutic use*
  • Ascorbic Acid Deficiency / complications
  • Cerebrovascular Disorders / surgery
  • Clinical Trials as Topic
  • Female
  • Fractures, Bone / surgery
  • Humans
  • Leukocytes / analysis
  • Male
  • Middle Aged
  • Paraplegia / complications
  • Postoperative Complications
  • Pressure Ulcer / blood
  • Pressure Ulcer / diagnosis
  • Pressure Ulcer / drug therapy*
  • Pressure Ulcer / etiology
  • Pressure Ulcer / prevention & control
  • Prospective Studies
  • Vascular Diseases / surgery
  • Wound Healing / drug effects

Substances

  • Ascorbic Acid